Natco Pharma Ltd (NATCOPHARM) is listed on the NSE in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry. Market capitalisation: 15829.73 Cr. Figures below are as reported and are shown with their source and date.
NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. The company is headquartered in Hyderabad, Telangana. The firm is engaged in the business of pharmaceuticals, which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations. The firm deals in the production of finished dosage formulations (FDF), which it sells in India, the United States and the Rest of the World, as well as active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic fusion technologies, production of high-potency APIs and peptides. The firm operates through two segments: pharmaceuticals and agrochemicals. The pharmaceuticals segment, the Company drives its sales through FDFs and APIs. The agrochemicals segment is focused on niche products, including pest management.
Source: finedge · as of 2026-09-29
Last close (₹): 784.45
Source: quantro_screener_metrics_job · as of 2026-10-21
Source: quantro_screener_metrics_job · as of 2026-10-22
| Year ended | Revenue (₹ Cr) | PAT (₹ Cr) | EPS (₹) |
|---|---|---|---|
| Mar 2026 | 4,078.3 | 1,418.5 | 79.2 |
| Mar 2025 | 4,429.5 | 1,885.4 | 105.26 |
| Mar 2024 | 3,998.8 | 1,388.3 | 77.51 |
| Mar 2023 | 2,707.1 | 715.3 | 39.2 |
| Mar 2022 | 1,944.8 | 170 | 9.31 |
Source: finedge · as of 2026-07-21
Source: finedge · as of 2026-03-31
Source: quantro_company_profiles · as of 2026-10-23
Figures computed 2026-10-23.